Fexofenadina Cipla shortage status
No active shortage currently reported by the regulators Mederti tracks.
Last updated 1 Nov 2026 · sourced from official medicines regulators
- Generic name (INN)
- Fexofenadina Cipla
- ATC code
- R06AX26
- Class
- Auto-created by Agencia Española de Medicamentos — Problemas de Suministro scraper
Recent shortage history
- Spain: resolved 22 Sept 2026 (began 15 Mar 2026)
- Spain: resolved 12 Aug 2026 (began 2 Oct 2024)
Frequently asked questions
Is Fexofenadina Cipla currently in shortage?
No active shortage of Fexofenadina Cipla is currently reported by any of the national medicines regulators Mederti tracks. Shortages can emerge quickly — this page updates daily from official sources.
Where does this Fexofenadina Cipla shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.
Related medicines
Dimenhydrinate(25 Mg/5 Ml) · Dimenhydrinate(50 Mg) · Dimenhydrinate · Brompheniramine Maleate · Chlorpheniramine Maleate(4 Mg) · Chlorpheniramine
Get alerted when Fexofenadina Cipla status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.